NPPA fixes prices of formulation of Atorvastatin

NEW DELHI: Drug price regulator, National Pharmaceutical Pricing Authority (NPPA) on Monday fixed the price of formulation of Atorvastatin, Clopidogrel and Asprin capsules used in the cardiovascular segment.

The regulator has fixed the maximum retail price of the combination of Atorvastatin, Clopidogrel and Asprin Capsule of different strengths at Rs 37.89 per strip of 10, according to the information available on its website.

NPPA has fixed the price of the combination using the power conferred by Drug Prices Control Order 1995, the regulator said in a statement.